What are the Implications of ERBB2 Overexpression?
Overexpression of ERBB2 is associated with several types of cancers, including breast, ovarian, and gastric cancers. In breast cancer, approximately 15-20% of cases exhibit ERBB2 overexpression. This overexpression leads to increased proliferation and survival of cancer cells, making the disease more aggressive and resistant to conventional therapies.
